Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow

OBJECTIVE: Coronary slow flow (CSF) is characterized by delayed opacification of distal epicardial coronary arteries without significant coronary stenosis. In addition, The changes of lipoprotein-associated phospholipase A2 (Lp-PLA(2)) as a significant predictive factor for CSF remain controversial....

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yao-dong, Pei, Yu-qiang, Wang, Rui, Yang, Jia-xing, Zhao, Yin-xin, Liu, Xiao-li, Shen, Hua, Ma, Qian, Zhang, Shuo, Ge, Hai-long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251718/
https://www.ncbi.nlm.nih.gov/pubmed/32460702
http://dx.doi.org/10.1186/s12872-020-01463-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251718/
https://www.ncbi.nlm.nih.gov/pubmed/32460702
http://dx.doi.org/10.1186/s12872-020-01463-8

Ejemplares similares